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Few cases of abdominal wall metastasis from a urothelial carcinoma were reported in the literature, and
those were mostly attributed to iatrogenic implantation after laparoscopic surgery or a percutaneous
nephrostomy. An 85-year-old man presented with an infraumbilical mass 6 months after transurethral
resection of a bladder tumor (TURBt) for a T4 urinary bladder urothelial carcinoma. Abdominal sonog-
raphy disclosed a 1.6 cm  1.5 cm subcutaneous hypoechoic lesion. Wide excision of the mass was
performed, and skin ﬂaps were used for skin coverage. A combination of the patient’s clinical history,
tumor morphology, and immunostaining results were compatible with the pathologic characteristic of
his previous bladder urothelial carcinoma. We present this rare case of solitary abdominal wall mass
metastasis from a urothelial carcinoma of the urinary bladder.
Copyright  2013, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
The common sites of metastasis of a urinary bladder urothelial
carcinoma are the liver, lungs, bones, adrenal gland, and perito-
neum. Bladder cancer may also spread by implantation of tumors in
abdominal wounds, exposed urothelium, resected prostatic fossa,
or a traumatized urethra. Similarly, tumor seeding from iatrogenic
procedures such as partial cystectomy, needle biopsy, and bladder
perforation during transurethral resection were reported. Subcu-
taneous metastatic masses from a primary bladder urothelial car-
cinoma are very rare and were only reported with advanced
disease. Herein, we describe a case of advanced urinary bladder
urothelial carcinoma presenting as solitary abdominal wall
metastasis with no accompanying symptoms.
2. Case report
An 85-year-old male patient had undergone transurethral
resection of a bladder tumor (TURBt) 6 months earlier. The bladder
tumor extended from the anterior bladder wall to the prostatic
urethra. The surgical course was uneventful, and no bladderung-Shan Medical University
ng 402, Taiwan.
ciation. Published by Elsevier Taiwperforation or extravasation was noted during TURBt. Histopa-
thology of the resected tumor revealed a high-grade, muscle-
invasive papillary urothelial carcinoma with prostatic invasion and
a staging of cT4N0M0 (Fig. 1A). The patient’s family refused addi-
tional surgery or adjuvant chemotherapy due to his advanced age
and poor general condition. After discharge, the patient made
intermittent follow-up visits.
He subsequently presented to our urology outpatient depart-
ment with a rapidly growing left infraumbilical abdominal wall
lump that developed over the previous 3.5 months, but complained
of no skin involvement or accompanying discomfort. All laboratory
evaluations were normal, and a physical examination revealed a
solid, movable, and nontender subcutaneous mass. Abdominal
sonography was performed and a 1.6 cm  1.5 cm subcutaneous
hypoechoic lesionwas found (Fig. 2). Wide excision of the mass was
performed, and skin ﬂaps were used for skin coverage. Cut surfaces
of the surgical specimens revealed a reddish-brown, well-capsu-
lated mass (Fig. 3). Microscopically, a well-differentiated metastatic
carcinoma composed of nests, cords, and dispersed pleomorphic
tumor cells was noted. The immunoproﬁles of the tumor cells
reacted positively to high-molecular-weight keratin, cytokeratin 7
(CK7), and p63 but negatively to CK20. Alcian blue staining was
positive for a myxoid background. A combination of the patient’s
clinical history, tumor morphology, and immunostaining results
were compatible with the pathologic characteristic of his previousan LLC. Open access under CC BY-NC-ND license.
Fig. 1. (A) Computed tomography, after initial transurethral resection of a bladder tumor, showing urinary bladder wall thickening with perivesical tissue fat stranding. (B)
Computed tomography, after excising the abdominal wall metastatic lesion, disclosing tumor recurrence over the right posterior wall of the urinary bladder and invasion of the
prostate gland.
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was performed 2 weeks after resection of the abdominal wall mass,
which demonstrated several enlarged para-aortic lymph nodes and
local recurrence in the urinary bladder and prostate (Fig.1B). A bone
scan revealed no deﬁnite bony metastases. We again suggested
further adjuvant chemotherapy, but the patient’s family remained
hesitant due to the same concerns regarding additional surgery.
3. Discussion
Bladder cancer has a variablemetastatic potential, and almost any
organ can be involved. Lymph nodes, bones, lungs, liver, and peri-
toneum are the most common sites of metastasis from bladder
cancer, and only ﬁve patients were reported to have metastases
located in other sites.1 Abdominal wall metastasis of a urothelial
carcinoma of the urinary bladder is a rare event typically found in
advanced-stage cancer. Only three cases were reported in the liter-
ature.2e4 Metastasis of bladder carcinoma to the abdominal wall
results mainly from iatrogenic seeding5,6 such as during a previous
laparotomy or laparoscopic surgery wound seeding, ﬁne-needle
aspiration biopsy tract implantation, or even intraperitoneal
bladder rupture with tumor spread during transurethral resection.7
Other causes include direct invasion from an underlying neoplasm,
lymphatic spread, or hematogenous spread.4 Lymphatic spread of
bladder cancer often results in locoregional metastasis overlying the
abdomen, thighs, and genitalia. In our case, no transabdominal wall
procedure had been performed, and no bladder perforation during
TURBt was noted. Bladder perforation in a patient with a bladder
tumor is a cause for concern, and there are several reports ofFig. 2. Sonography revealing a well-circumscribed hypoechoic lesion approximately
1.6 cm  1.5 cm over the subcutaneous level.peritoneal or abdominal wall metastases after bladder perforation
during TURBt.8 In this case, there was no direction invasion of the
abdominal wall seen with CT, and only enlarged para-aortic lymph
nodes were found. Thus, the pathological process seemed to be a
result of hematogenous or lymphatic metastasis rather than multi-
centricity or implantation. Metastasis from a urothelial carcinoma
usually involves multiple organs. In particular, when a metastatic
lesion develops soon after primary tumor treatment, further evalu-
ation of other organs may be warranted. Abdominal wall metastasis
from the urinary tract may be an ominous sign, and such lesions
should be assessed as part of the overall staging. Although abdominal
wall lesions represented a solitary site of metastasis at presentation,
during follow-up, most of the patients subsequently developed
widespread disease and died in a mean duration of 8 months.
Effective palliation can be achieved with chemotherapy with or
without the addition of local radiotherapy; however, abdominal wall
metastases of a urothelial carcinoma have a poor prognosis.9
Wide excision of abdominal wall metastatic lesions should be
considered ﬁrst if feasible, and systemic chemotherapy considered
as a possible therapeutic option. However, although some cases
were reported to respond to systematic chemotherapy, this
metastasis usually portends rapid progression of the disease and a
poor prognosis.10
In conclusion, we present an unusual case of a urothelial carci-
noma where the patient was completely asymptomatic with a
solitary subcutaneous lump. Whenever an abdominal wall tumor is
found in a patient with a history of bladder cancer, metastasis from
a bladder malignancy should be considered as a potential cause.
We recommend that patients with new-onset masses shouldFig. 3. Gross photograph of the cut surface of the excised metastatic mass.
Fig. 4. (A) Original bladder urothelial carcinoma pathology (hematoxylin and eosin, original magniﬁcation, 200). (B) Excised metastatic abdominal mass pathology (high-mo-
lecular-weight keratin, original magniﬁcation, 400).
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whether or not symptoms are present.
Conﬂicts of interest statement
The authors declare that they have no ﬁnancial or non-ﬁnancial
conﬂicts of interest related to the subject matter or materials dis-
cussed in the manuscript.
Sources of funding
None.
References
1. Shinagare AB, Ramaiya NH, Jagannathan JP, Fennessy FM, Taplin ME, Van den
Abbeele AD. Metastatic pattern of bladder cancer: correlation with the char-
acteristics of the primary tumor. Am J Roentgenol 2011;196:117e22.
2. Spector JI, Zimbler H, DeLeo M, Ross JS. Skin metastasis from transitional cell
carcinoma. Urology 1987;29:215e7.3. Elston DM, Tuthill RJ, Pierson J, Marden JD, Bergfeld WF. Carcinoma erysipe-
latoides resulting from genitourinary cancer. J Am Acad Dermatol 1996;35:
993e5.
4. Ku JH, Yeo WG, Park MY, Lee ES, Kim HH. Metastasis of transitional cell car-
cinoma to the lower abdominal wall 20 years after cystectomy. Yonsei Med J
2005;46:181e3.
5. Andersen JR, Steven K. Implantation metastasis after laparoscopic biopsy of
bladder cancer. J Urol 1995;153:1047e8.
6. Otani M, Irie S, Tsuji Y. Port site metastasis after laparoscopic nephrectomy:
unsuspected transitional cell carcinoma within a tuberculous atrophic kidney.
J Urol 1999;162:486e7.
7. Swick BL, Gordon JR. Superﬁcially invasive transitional cell carcinoma of the
bladder associated with distant cutaneous metastases. J Cutan Pathol 2010;37:
1245e50.
8. Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ. Long-term conse-
quences from bladder perforation and/or violation in the presence of transi-
tional cell carcinoma: results of a small series and a review of the literature.
J Urol 1999;161:1128e32.
9. Nabi G, Gupta NP, Gandhi D. Skeletal muscle metastasis from transitional cell
carcinoma of the urinary bladder: clinicoradiological features. Clin Radiol
2003;58:883e5.
10. Ando K, Goto Y, Kato K, Murase T, Matsumoto Y, Ohashi M. Zosteriform in-
ﬂammatory metastatic carcinoma from transitional cell carcinoma of the renal
pelvis. J Am Acad Dermatol 1994;31:284e6.
